Skip to main content
Medartis Holding AG logo

Medartis Holding AG — Investor Relations & Filings

Ticker · MED ISIN · CH0386200239 LEI · 506700VUSP6HG3F28846 SW Manufacturing
Open in API
Filings indexed 101 across all filing types
Latest filing 2026-04-23 Declaration of Voting R…
Country CH Switzerland
Listing SW MED

About Medartis Holding AG

https://www.medartis.com/

Medartis Holding AG is a medical device company that develops, manufactures, and distributes implant solutions for the surgical fixation of bone fractures. The company provides precision-engineered system solutions, including titanium screws, plates, and surgical instruments. Its primary focus is on osteosynthesis for the upper and lower extremities, as well as for cranio-maxillofacial surgery. Medartis offers comprehensive solutions designed to support surgeons and facilitate optimal patient care in fracture fixation procedures.

Recent filings

Filing Released Lang Actions
Medartis shareholders endorse Board proposals with strong support at AGM 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release detailing the results of the 2026 Annual General Meeting, including voting percentages for each board proposal, election of directors, approval of remuneration and financial statements, and detailed vote outcomes. This directly corresponds to a declaration of voting results at an AGM rather than an actual AGM presentation, annual report, or a different corporate announcement. Therefore, it fits the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-04-23 English
Medartis shareholders endorse Board proposals with strong support at AGM 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release reporting the voting outcomes of the 2026 Annual General Meeting, detailing vote percentages for board elections, approval of remuneration, annual financial statements, and other resolutions. It does not present the AGM materials themselves nor constitute an annual report or financial statement; rather it declares the results of shareholder votes. Therefore, it is a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-04-23 English
Medartis-Aktionär:innen stimmen den Vorschlägen des Verwaltungsrats an der GV 2026 mit starker Unterstützung zu
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is a media release detailing the results of the 2026 Annual General Meeting of Medartis Holding AG, including vote percentages, election outcomes, approvals of financial statements, discharge of board, and compensation votes. It is clearly a declaration of shareholder voting results at a general meeting, matching the "Declaration of Voting Results & Voting Rights Announcements" category.
2026-04-23 German
Medartis builds on momentum with 16% organic sales growth and core EBITDA margin exceeding 18%
Earnings Release Classification · 95% confidence The document is an 'Ad hoc announcement' detailing full-year 2025 financial results, including sales growth, EBITDA margins, regional performance, and M&A activity. It provides key financial highlights and management commentary. While it contains financial data, it is an initial announcement of results rather than the full audited Annual Report (10-K) or a standalone audit report. It fits the definition of an Earnings Release (ER) as it is the primary communication of periodic financial performance. FY 2025
2026-03-17 English
Medartis builds on momentum with 16% organic sales growth and core EBITDA margin exceeding 18%
Earnings Release Classification · 95% confidence The document is an 'Ad hoc announcement' detailing full-year 2025 financial results, including sales growth, EBITDA margins, regional performance, and M&A activity. It provides key financial highlights and management commentary. While it contains detailed financial information, it is structured as an initial earnings release announcement (indicated by the 'Ad hoc announcement' header and the release date/time format) rather than the full audited Annual Report (10-K) or a standalone management report (MDA). Therefore, it is classified as an Earnings Release. FY 2025
2026-03-17 English
Medartis setzt Aufwärtstrend fort: Organisches Umsatzwachstum von 16 % und Kern-EBITDA-Marge über 18 %
Earnings Release Classification · 95% confidence The document is an 'Ad hoc-Mitteilung' (Ad hoc announcement) issued by Medartis Holding AG on March 17, 2026, detailing their full-year 2025 financial results, including revenue growth, EBITDA margins, and strategic acquisitions. While it contains financial data, it is the initial press release/announcement of these results rather than the full audited Annual Report (10-K). According to the 'Menu vs Meal' rule, this is an Earnings Release (ER) as it provides key highlights, management commentary, and financial tables for the period. FY 2025
2026-03-17 German

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.